(MDGL) Madrigal - Performance 7.7% in 12m
MDGL performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
63.43%
#6 in Peer-Group
Rel. Strength
50.08%
#3708 in Stock-Universe
Total Return 12m
7.68%
#59 in Peer-Group
Total Return 5y
192.73%
#6 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 355.88 USD |
| 52 Week Low | 202.48 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 86.43 |
| Buy/Sell Signal +-5 | -1.05 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: MDGL (7.7%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.31% | 66.4% | 81.3% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.3% | -10.9% | 137% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
2.47% | 33.7% | 4.38% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
1.42% | -10.5% | -0.06% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.2% | 64.2% | 3.4% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
1.94% | 59.9% | -1.58% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.88% | 35.5% | 16% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: MDGL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MDGL
| Total Return (including Dividends) | MDGL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 11.42% | 3.18% | 4.55% |
| 3 Months | -9.20% | 2.36% | 10.78% |
| 12 Months | 7.68% | -10.75% | 14.71% |
| 5 Years | 192.73% | -24.51% | 112.53% |
| Trend Score (consistency of price movement) | MDGL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 64.7% | 18.8% | 79.2% |
| 3 Months | -70.9% | 71.5% | 92.9% |
| 12 Months | 45.6% | -84.3% | 44.2% |
| 5 Years | 69.9% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th75.00 | 7.99% | 6.60% |
| 3 Month | %th39.00 | -11.30% | -17.64% |
| 12 Month | %th71.00 | 20.65% | -5.68% |
| 5 Years | %th97.50 | 287.76% | 34.95% |
FAQs
Does Madrigal (MDGL) outperform the market?
Yes,
over the last 12 months MDGL made 7.68%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.75%.
Over the last 3 months MDGL made -9.20%, while XBI made 2.36%.
Performance Comparison MDGL vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
MDGL vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.3% | 6.9% | -9.5% | -7% |
| US NASDAQ 100 | QQQ | 3.2% | 5.9% | -10.1% | -7% |
| German DAX 40 | DAX | 3% | 11.1% | -23.8% | -23% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.7% | 7.3% | -7.5% | -10% |
| Hongkong Hang Seng | HSI | 3.8% | 5.6% | -25.3% | -28% |
| India NIFTY 50 | INDA | 3.4% | 9.1% | -9.6% | 8% |
| Brasil Bovespa | EWZ | 2% | 3.7% | -34% | -6% |
MDGL vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.6% | 4.5% | -15% | -20% |
| Consumer Discretionary | XLY | 4.3% | 9.5% | -0.7% | -13% |
| Consumer Staples | XLP | 7.3% | 12.7% | -7.5% | -1% |
| Energy | XLE | 7.1% | 6.9% | -6% | 11% |
| Financial | XLF | 4.1% | 8.9% | -11.8% | -20% |
| Health Care | XLV | 4.9% | 9.8% | -1.9% | 14% |
| Industrial | XLI | 4.2% | 8.3% | -15.4% | -16% |
| Materials | XLB | 5.2% | 9.1% | -9.4% | 5% |
| Real Estate | XLRE | 8.5% | 11.9% | -7% | -4% |
| Technology | XLK | 3% | 3% | -10.8% | -3% |
| Utilities | XLU | 6.2% | 10.4% | -12.4% | -16% |
| Aerospace & Defense | XAR | 2% | 1.8% | -29.7% | -44% |
| Biotech | XBI | 5.4% | 8.2% | 4.2% | 18% |
| Homebuilder | XHB | 5.2% | 7.5% | 1.8% | 7% |
| Retail | XRT | 6.1% | 9.3% | -1.2% | 1% |
MDGL vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 10.4% | 2.36% | -1.43% | 18% |
| Natural Gas | UNG | 8.1% | 8% | 4.8% | 8% |
| Gold | GLD | 9.5% | 12.9% | -28.7% | -32% |
| Silver | SLV | 7.3% | 3.8% | -26.9% | -14% |
| Copper | CPER | 3.1% | 7.2% | -29.3% | -8% |
MDGL vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 5.6% | 9.6% | -4.8% | 7% |
| iShares High Yield Corp. Bond | HYG | 5.8% | 9.9% | -8.1% | -3% |